,i #aac? ,,congress #a/ ,session ,h4 ,r4 #afjh ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,april #ag1 #bjac ,mr4 ,ow5s introduc$ ! foll[+ bill2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,a ,,bill ,to require ! ,secret>y ( ,heal? & ,human ,s]vices to promulgate regulations reg>d+ ! au?or%ip1 cont5t1 =mat1 & dissem9ation ( ,pati5t ,m$ication ,in=mation to ensure pati5ts receive consi/5t & high-quality in=mation ab\t _! prescription m$ications & are aw>e ( ! pot5tial risks & b5efits ( prescription m$ications4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,cody ,mill] ,initiative = ,saf] ,prescriptions ,act4 #b4 ,pati5t m$ication in=mation = prescription drugs ,*apt] ,v ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cea et seq47 is am5d$ by ins]t+ aft] section #eje;,d ! foll[+3 #eje;,e4 ,pati5t m$ication in=mation = prescription drugs 7a7 ,9 g5]al ,n lat] ?an #b ye>s aft] ! date ( enactm5t ( ?is section1 ! ,secret>y %all issue regulations reg>d+ ! au?or%ip1 cont5t1 =mat1 & dissem9ation requirem5ts = pati5t m$ication in=mation 7ref]r$ to 9 ?is section z ,,pmi7 = drugs subject to section #ejc7;b77#a74 7b7 ,cont5t ,! regulations promulgat$ "u subsection 7a7 %all require t ! ,,pmi ) respect to a drug-- 7#a7 be sci5tifically accurate & bas$ on ! pr(essional label+ approv$ by ! ,secret>y & au?oritative1 pe]-review$ lit]ature2 & 7#b7 includes nonte*nical1 und]/&able1 pla9 language t is n promotional 9 tone or cont5t1 & conta9s at lea/-- 7,a7 ! e/abli%$ "n ( drug1 includ+ ! e/abli%$ "n ( su* drug z a li/$ drug 7z describ$ 9 section #eje7;j77#b77;,a77 & z a drug t is ! subject ( an approv$ abbreviat$ new drug application "u section #eje7;j7 or ( an approv$ lic5se = a biological product submitt$ "u section #cea7k7 ( ! ,public ,heal? ,s]vice ,act1 if applicable2 7,b7 drug uses & cl9ical b5efits2 7,c7 g5]al directions = prop] use2 7,d7 contra9dications1 common side effects1 & mo/ s]i\s risks ( ! drug1 especially ) respect to c]ta9 gr\ps su* z *ildr51 pregnant wom51 & ! eld]ly2 7,e7 measures pati5ts may be able to take1 if any1 to r$uce ! side effects & risks ( ! drug2 7,f7 :5 a pati5t %\ld contact 8 or h] heal? c>e pr(essional2 7,g7 in/ructions n to %>e m$ications1 &1 if any exi/1 key /orage requirem5ts1 & recomm5dations relat+ to prop] disposal ( any unus$ portion ( ! drug2 & 7,h7 kn[n cl9ically important int]actions ) o!r drugs & sub/ances4 7c7 ,timel9ess1 consi/5cy1 & accuracy ,! regulations promulgat$ "u subsection 7a7 %all include /&>ds relat$ to-- 7#a7 p]=m+ timely updates ( drug in=mation z new drugs & new in=mation becomes available2 7#b7 ensur+ t common in=mation is appli$ consi/5tly & simultane\sly across simil> drug products & = drugs )9 classes ( m$ications 9 ord] to avoid pati5t confusion & h>m2 & 7#c7 develop+ a process1 includ+ consum] te/+1 to assess ! quality & effectiv5ess ( ,,pmi 9 ensur+ t ,,pmi promotes pati5t und]/&+ & safe & effective m$ication use4 7d7 ,electronic repository ,! regulations promulgat$ "u subsection 7a7 %all provide = ! developm5t ( a publicly accessible electronic repository = all ,,pmi docum5ts & cont5t to facilitate ! availability ( ,,pmi4 4 #c4 ,publication on int]net ,web site ,! ,secret>y ( ,heal? & ,human ,s]vices %all publi% on ! ,int]net ,web site ( ! ,food & ,drug ,adm9i/ration a l9k to ! ,daily ,m$ ,web site 7http3_/_/dailym$4nlm4nih4gov_/dailym$7 7or any successor ,web site74